Dapoxetine is not approved by the FDA and is not legally available in the United States. No oral medication for premature ejaculation has ever received FDA approval, making the U.S. an outlier compared to more than 50 countries where dapoxetine is marketed under the brand name Priligy. Despite this, several effective treatment options exist for men in the U.S. dealing with premature ejaculation.
Why the FDA Rejected Dapoxetine
The drug came close to reaching the U.S. market. In December 2004, Janssen-Cilag submitted a New Drug Application to the FDA for dapoxetine. The agency issued a “not approvable” letter in October 2005, and no company has successfully refiled since. The last U.S. Phase 3 clinical trial for dapoxetine wrapped up in 2006, and no active trials are currently registered.
The specific reasons behind the FDA’s rejection have never been made fully public, but the drug’s safety profile likely played a role. In large clinical trials, nausea was common: about 11% of men taking the lower dose (30 mg) and 22% on the higher dose (60 mg) reported it, compared to just 2.2% on placebo. A more concerning signal was syncope, or fainting. While rare overall, it occurred in roughly 1 in 435 men on the higher dose, about four times the rate seen with placebo.
Where Dapoxetine Is Approved
Dapoxetine is widely available across Europe. According to the European Medicines Agency, it holds national marketing authorizations in 26 European countries, including Germany, France, Italy, Spain, and Ireland. It is also approved in parts of Asia, South America, and elsewhere, totaling more than 50 countries worldwide. In these markets, it’s sold as Priligy in 30 mg and 60 mg tablets, taken one to three hours before sexual activity and no more than once in a 24-hour period.
What Makes Dapoxetine Different
Dapoxetine belongs to the same drug class as common antidepressants like sertraline and paroxetine (SSRIs), but it was specifically engineered for on-demand use rather than daily dosing. It reaches peak levels in the blood within about 1.4 hours, faster than any other SSRI. It also clears the body quickly. Plasma levels drop to roughly 5% of their peak within 24 hours, which means the drug doesn’t build up in your system over time. This rapid in, rapid out profile is what makes it work as a take-it-when-you-need-it treatment, unlike traditional SSRIs that require days or weeks of daily use to reach a steady therapeutic effect.
Can You Import It for Personal Use?
Technically, importing an unapproved drug into the U.S. is illegal. The FDA states this plainly on its website. However, the agency does outline situations where enforcement staff may exercise discretion, such as when there’s no effective domestic treatment available, the product doesn’t pose an unreasonable health risk, the quantity is no more than a three-month supply, and the individual provides the name of a U.S.-licensed doctor overseeing their care.
This is not a green light. It’s a description of when the FDA may choose not to act, not a guarantee. Online pharmacies selling Priligy to U.S. customers operate in a legal gray zone, and the quality and authenticity of products purchased this way is impossible to verify.
Treatment Options Available in the U.S.
The American Urological Association recommends three first-line approaches for premature ejaculation: daily SSRIs, on-demand clomipramine or dapoxetine (where available), and topical numbing agents applied to the penis. Since dapoxetine isn’t available here, U.S. treatment relies on the other two categories, all used off-label.
Paroxetine is considered the most effective daily SSRI option for this purpose, typically prescribed at 10 to 40 mg per day. It can also be used on demand at 20 mg, taken three to four hours before intercourse. Sertraline is another common choice at 25 to 200 mg daily, or 50 mg taken four to eight hours beforehand. Fluoxetine rounds out the options at 5 to 20 mg daily. These medications were developed for depression and anxiety, so none carry an FDA indication for premature ejaculation, but their use for this purpose is well-supported by clinical evidence and endorsed in professional guidelines.
The key tradeoff compared to dapoxetine is timing and side effects. Daily SSRIs take one to two weeks of consistent use before they begin delaying ejaculation, and stopping them can cause withdrawal symptoms. Dapoxetine’s design avoids both of these issues, which is why it remains appealing to patients and clinicians despite its U.S. absence.
Topical Numbing Agents
Over-the-counter sprays and creams containing lidocaine or benzocaine are the most accessible option in the U.S. These work by reducing sensitivity at the surface of the skin and are applied to the head of the penis 10 to 20 minutes before intercourse. Lidocaine-based sprays have been used for this purpose for over 25 years in some countries. They avoid the systemic side effects of oral medications like nausea or fatigue, though they can reduce sensation for a partner if not used carefully (a condom helps prevent transfer).
For many men, combining a topical product with behavioral techniques like the stop-start method provides meaningful improvement without the commitment of a daily medication or the regulatory hurdles of an unavailable drug.